Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals is a development-stage pharmaceutical company focused on developing drugs for oncology and other high unmet medical needs.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Processa Pharmaceuticals, Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology and other high unmet medical need diseases. The company focuses on acquiring de-risked, preclinical- and clinical-stage assets and applying regulatory science to navigate drugs efficiently through FDA approval. Its portfolio includes licensed products such as PCS499, PCS12852, and PCS11T.
History
Processa Pharmaceuticals, Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology and other high unmet medical need diseases. The company focuses on acquiring de-risked, preclinical- and clinical-stage assets and applying regulatory science to navigate drugs efficiently through FDA approval. Its portfolio includes licensed products such as PCS499, PCS12852, and PCS11T.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/processa-pharmaceuticals-inc-united-states · Editorial policy · How profiles are compiled